APA (7th ed.) Citation

X, H., V, Z., C, X., E, J., Y, L., C, W., . . . SJ, W. (2025). Antitumor activity of rucaparib plus PLX038A in serous endometrial carcinoma. Journal of experimental & clinical cancer research : CR, 44(1), 150. https://doi.org/10.1186/s13046-025-03406-7

Chicago Style (17th ed.) Citation

X, Hou, et al. "Antitumor Activity of Rucaparib Plus PLX038A in Serous Endometrial Carcinoma." Journal of Experimental & Clinical Cancer Research : CR 44, no. 1 (2025): 150. https://doi.org/10.1186/s13046-025-03406-7.

MLA (9th ed.) Citation

X, Hou, et al. "Antitumor Activity of Rucaparib Plus PLX038A in Serous Endometrial Carcinoma." Journal of Experimental & Clinical Cancer Research : CR, vol. 44, no. 1, 2025, p. 150, https://doi.org/10.1186/s13046-025-03406-7.